MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by COULTER, A. W.
Right arrow Articles by TALALAY, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by COULTER, A. W.
Right arrow Articles by TALALAY, P.

Molecular Pharmacology, Vol 10, 305-314, Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics

Structural and Conformational Analogues of L-Methionine as Inhibitors of the Enzymatic Synthesis of S-Adenosyl-L-Methionine

II. Aromatic Amino Acids

A. W. COULTER 1, J. B. LOMBARDINI 1, and PAUL TALALAY 1

1 Department of Pharmacology and Experimental Therapeutics, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

A series of aromatic amino acids structurally related to L-methionine were synthesized as potential inhibitors of the enzymatic formation of S-adenosyl-L-methionine by partially purified preparations of ATP:L-methionine S-adenosyltransferase (EC 2.5.1.6) of bakers’ yeast, Escherichia coli, and rat liver. 2-Amino-5-phenylpentanoic acid was a considerably better inhibitor of the liver enzyme than 2-aminopentanoic acid (norvaline) but produced no inhibition of the yeast and E. coli enzymes. (E)-2-Amino-5-phenyl-4-pentenoic and 2-amino-5-phenyl-4-pentynoic acids were superior in their inhibitory activity to the corresponding chain-saturated analogues. The phenyl group thus imparts a favorable influence on the inhibitory power. S-Phenyl-DL-homocysteine is an even more potent inhibitor of the liver enzyme, but is also devoid of activity in the microbial enzyme systenms. O-Phenyl-DL-homoserine displays similar properties, but was not quite as effective as the sulfur analogue. In order to evaluate the effect of electron-donating and electron-withdrawing substituents on the phenyl ring, the following compounds were synthesized: O-(p-fluorophenyl)-DL-homoserine, O-(p-chlorophenyl)-DL-homoserine, O-(p-bromophenyl)-DL-homoserine, O-(p-nitrophenyl)-DL-homosenine, O-(p-methoxyphenyl)-DL-homoserine, O-(p-methylphenyl)-DL-homoserine, O-(m-chorophenyl)-DL-homoserine, O-(m-bromophenyl)-DL-homoserine, O-(m-nitrophenyl)-DL-homoserine, and O-(m-methoxyphenyl)-DL-homoserine. When the inhibitory potencies of these compounds (expressed as pI50 values) were analyzed in terms of the Hammett sgr values of the substituents, the inhibitory potency was correlated with the positive magnitudes of the sgr values. If the anomalous nitro compounds are excluded, the Hammett sigma-rho equation PI50 = 1.45sgr + 1.82 is obtained by least-squares linear regression analysis. This finding suggests that the electron-withdrawing substituents are most favorable for inhibition, and that the creation in the analogue of a partial positive charge at the heteroatom bearing the phenyl group may resemble most closely the transition state of the enzymatic reaction, in which the thioether group of L-methionine is converted to the positively charged sulfonium group of S-adenosyl-L-methionine. O-Methyl-DL-homoserine is a strong inhibitor of the adenosyltransferases of yeast, E. coli, and rat liver, and especially powerful for the E. coli enzyme. Since it has been shown that this compound inhibits the growth of certain microorganisms and viruses, as well as displaying certain specific toxicities in rodents the possibility should be considered that these effects are due to inhibition of the adenosyltransferase reaction.

Note:
ACKNOWLEDGMENTS The authors are grateful to Mrs. Mary Karen Burch, Mrs. JoAnn Kaufmann, and Mrs. Patricia M. Margulies for skillful assistance in various aspects of these studies. We wish to thank Dr. Cathrine Fenselau for consultation on mass spectrometric analyses, and Dr. Cecil H. Robinson for much valuable advice. Miss Rachel Talalay assisted with some of the regression analyses.

Submitted on August 20, 1973







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics